Renner Kathrin, Amberger Albert, Konwalinka Günther, Kofler Reinhard, Gnaiger Erich
Tyrolean Cancer Research Institute, Innrain 66, A-6020 Innsbruck, Austria.
Biochim Biophys Acta. 2003 Sep 23;1642(1-2):115-23. doi: 10.1016/s0167-4889(03)00105-8.
Mitochondrial damage with release of cytochrome c is implicated in cell death signalling pathways. To examine mitochondrial function in apoptotic cells, we applied high-resolution respirometry to human leukemia cells arrested in the G1- and S-phase by exposure to the glucocorticoid dexamethasone and nucleotide analogue gemcitabine. At 30% apoptosis, opposite effects were observed on respiratory capacity (71% and 131% of controls, respectively). These changes correlated with alterations in cell size, cytosolic, and mitochondrial marker enzymes. Mitochondrial ATP production and membrane potential were maintained in all treatments, as deduced from high respiratory uncoupling control ratios (UCR). Bcl-2 over-expression did not prevent apoptosis after gemcitabine-treatment, but protected dexamethasone-treated cells from apoptosis, without fully preventing the decline of respiration and cell size. These results, therefore, provide conclusive evidence that alterations in respiratory capacity and enzyme activities per cell are mainly caused by opposite changes in cell size, occurring upon cell cycle arrest triggered by dexamethasone and gemcitabine in the early phase of apoptosis.
细胞色素c的释放所导致的线粒体损伤与细胞死亡信号通路有关。为了检测凋亡细胞中的线粒体功能,我们对通过暴露于糖皮质激素地塞米松和核苷酸类似物吉西他滨而停滞在G1期和S期的人白血病细胞应用了高分辨率呼吸测定法。在凋亡率为30%时,观察到对呼吸能力有相反的影响(分别为对照的71%和131%)。这些变化与细胞大小、胞质和线粒体标记酶的改变相关。从高呼吸解偶联控制率(UCR)推断,在所有处理中,线粒体ATP产生和膜电位均得以维持。Bcl-2过表达并不能阻止吉西他滨处理后的细胞凋亡,但可保护地塞米松处理的细胞免于凋亡,却不能完全阻止呼吸和细胞大小的下降。因此,这些结果提供了确凿的证据,表明每个细胞的呼吸能力和酶活性的改变主要是由细胞大小的相反变化所引起的,这种变化发生在凋亡早期由地塞米松和吉西他滨触发的细胞周期停滞时。